nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Topotecan—lung cancer	0.0946	0.142	CbGbCtD
Fosamprenavir—CYP3A4—Gefitinib—lung cancer	0.0865	0.13	CbGbCtD
Fosamprenavir—CYP3A4—Teniposide—lung cancer	0.0839	0.126	CbGbCtD
Fosamprenavir—CYP3A4—Vinorelbine—lung cancer	0.0666	0.1	CbGbCtD
Fosamprenavir—CYP3A4—Crizotinib—lung cancer	0.053	0.0796	CbGbCtD
Fosamprenavir—CYP3A4—Erlotinib—lung cancer	0.0511	0.0768	CbGbCtD
Fosamprenavir—CYP3A4—Paclitaxel—lung cancer	0.0468	0.0703	CbGbCtD
Fosamprenavir—CYP3A4—Irinotecan—lung cancer	0.0462	0.0694	CbGbCtD
Fosamprenavir—CYP3A4—Vinblastine—lung cancer	0.0411	0.0617	CbGbCtD
Fosamprenavir—CYP3A4—Etoposide—lung cancer	0.037	0.0556	CbGbCtD
Fosamprenavir—CYP3A4—Docetaxel—lung cancer	0.0338	0.0508	CbGbCtD
Fosamprenavir—CYP3A4—Doxorubicin—lung cancer	0.0252	0.0379	CbGbCtD
Fosamprenavir—CYP3A4—Felbamate Metabolism—CYP2E1—lung cancer	0.000993	0.0907	CbGpPWpGaD
Fosamprenavir—Erythema multiforme—Etoposide—lung cancer	0.000531	0.00165	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.00053	0.00164	CcSEcCtD
Fosamprenavir—Flatulence—Cisplatin—lung cancer	0.000526	0.00163	CcSEcCtD
Fosamprenavir—Cardiac disorder—Etoposide—lung cancer	0.000522	0.00162	CcSEcCtD
Fosamprenavir—Erythema multiforme—Paclitaxel—lung cancer	0.000521	0.00161	CcSEcCtD
Fosamprenavir—Hypersensitivity—Vinblastine—lung cancer	0.000516	0.0016	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.000516	0.0016	CcSEcCtD
Fosamprenavir—Amprenavir—ABCB1—lung cancer	0.000514	1	CrCbGaD
Fosamprenavir—Acute coronary syndrome—Docetaxel—lung cancer	0.000513	0.00159	CcSEcCtD
Fosamprenavir—Cardiac disorder—Paclitaxel—lung cancer	0.000511	0.00159	CcSEcCtD
Fosamprenavir—Myocardial infarction—Docetaxel—lung cancer	0.00051	0.00158	CcSEcCtD
Fosamprenavir—Immune system disorder—Etoposide—lung cancer	0.000508	0.00157	CcSEcCtD
Fosamprenavir—Decreased appetite—Vinorelbine—lung cancer	0.000506	0.00157	CcSEcCtD
Fosamprenavir—Asthenia—Vinblastine—lung cancer	0.000503	0.00156	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000503	0.00156	CcSEcCtD
Fosamprenavir—CYP3A4—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.000502	0.0459	CbGpPWpGaD
Fosamprenavir—Fatigue—Vinorelbine—lung cancer	0.000502	0.00156	CcSEcCtD
Fosamprenavir—Hypersensitivity—Topotecan—lung cancer	0.000501	0.00155	CcSEcCtD
Fosamprenavir—Immune system disorder—Paclitaxel—lung cancer	0.000498	0.00154	CcSEcCtD
Fosamprenavir—Asthenia—Topotecan—lung cancer	0.000488	0.00151	CcSEcCtD
Fosamprenavir—Myalgia—Gemcitabine—lung cancer	0.000488	0.00151	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Doxorubicin—lung cancer	0.000485	0.0015	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000484	0.0015	CcSEcCtD
Fosamprenavir—Asthenia—Erlotinib—lung cancer	0.000483	0.0015	CcSEcCtD
Fosamprenavir—Pruritus—Topotecan—lung cancer	0.000481	0.00149	CcSEcCtD
Fosamprenavir—Malnutrition—Paclitaxel—lung cancer	0.00048	0.00149	CcSEcCtD
Fosamprenavir—Diarrhoea—Vinblastine—lung cancer	0.000479	0.00149	CcSEcCtD
Fosamprenavir—Pruritus—Erlotinib—lung cancer	0.000476	0.00148	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Vinorelbine—lung cancer	0.000476	0.00148	CcSEcCtD
Fosamprenavir—Flatulence—Paclitaxel—lung cancer	0.000473	0.00147	CcSEcCtD
Fosamprenavir—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—lung cancer	0.000472	0.0432	CbGpPWpGaD
Fosamprenavir—Nervous system disorder—Irinotecan—lung cancer	0.000471	0.00146	CcSEcCtD
Fosamprenavir—Haemoglobin—Docetaxel—lung cancer	0.00047	0.00146	CcSEcCtD
Fosamprenavir—Haemorrhage—Docetaxel—lung cancer	0.000467	0.00145	CcSEcCtD
Fosamprenavir—Diarrhoea—Topotecan—lung cancer	0.000466	0.00144	CcSEcCtD
Fosamprenavir—Dizziness—Vinblastine—lung cancer	0.000463	0.00144	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Docetaxel—lung cancer	0.000461	0.00143	CcSEcCtD
Fosamprenavir—Diarrhoea—Erlotinib—lung cancer	0.000461	0.00143	CcSEcCtD
Fosamprenavir—Abdominal pain—Vinorelbine—lung cancer	0.00046	0.00143	CcSEcCtD
Fosamprenavir—Body temperature increased—Vinorelbine—lung cancer	0.00046	0.00143	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Docetaxel—lung cancer	0.000459	0.00142	CcSEcCtD
Fosamprenavir—Nervous system disorder—Gemcitabine—lung cancer	0.000459	0.00142	CcSEcCtD
Fosamprenavir—Urethral disorder—Docetaxel—lung cancer	0.000458	0.00142	CcSEcCtD
Fosamprenavir—Anorexia—Irinotecan—lung cancer	0.000458	0.00142	CcSEcCtD
Fosamprenavir—Myalgia—Cisplatin—lung cancer	0.000455	0.00141	CcSEcCtD
Fosamprenavir—Skin disorder—Gemcitabine—lung cancer	0.000454	0.00141	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000452	0.0014	CcSEcCtD
Fosamprenavir—Dizziness—Topotecan—lung cancer	0.00045	0.00139	CcSEcCtD
Fosamprenavir—Anorexia—Gemcitabine—lung cancer	0.000446	0.00138	CcSEcCtD
Fosamprenavir—Vomiting—Vinblastine—lung cancer	0.000445	0.00138	CcSEcCtD
Fosamprenavir—Dizziness—Erlotinib—lung cancer	0.000445	0.00138	CcSEcCtD
Fosamprenavir—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—lung cancer	0.000443	0.0405	CbGpPWpGaD
Fosamprenavir—Erythema multiforme—Docetaxel—lung cancer	0.000442	0.00137	CcSEcCtD
Fosamprenavir—Headache—Vinblastine—lung cancer	0.000439	0.00136	CcSEcCtD
Fosamprenavir—Angioedema—Paclitaxel—lung cancer	0.000438	0.00136	CcSEcCtD
Fosamprenavir—Cardiac disorder—Docetaxel—lung cancer	0.000434	0.00134	CcSEcCtD
Fosamprenavir—Vomiting—Topotecan—lung cancer	0.000433	0.00134	CcSEcCtD
Fosamprenavir—Rash—Topotecan—lung cancer	0.000429	0.00133	CcSEcCtD
Fosamprenavir—Hypersensitivity—Vinorelbine—lung cancer	0.000429	0.00133	CcSEcCtD
Fosamprenavir—Dermatitis—Topotecan—lung cancer	0.000429	0.00133	CcSEcCtD
Fosamprenavir—Vomiting—Erlotinib—lung cancer	0.000428	0.00133	CcSEcCtD
Fosamprenavir—Nervous system disorder—Cisplatin—lung cancer	0.000427	0.00132	CcSEcCtD
Fosamprenavir—Headache—Topotecan—lung cancer	0.000426	0.00132	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000426	0.00132	CcSEcCtD
Fosamprenavir—Rash—Erlotinib—lung cancer	0.000425	0.00132	CcSEcCtD
Fosamprenavir—Dermatitis—Erlotinib—lung cancer	0.000424	0.00131	CcSEcCtD
Fosamprenavir—Skin disorder—Cisplatin—lung cancer	0.000423	0.00131	CcSEcCtD
Fosamprenavir—Immune system disorder—Docetaxel—lung cancer	0.000422	0.00131	CcSEcCtD
Fosamprenavir—Headache—Erlotinib—lung cancer	0.000422	0.00131	CcSEcCtD
Fosamprenavir—Asthenia—Vinorelbine—lung cancer	0.000418	0.00129	CcSEcCtD
Fosamprenavir—Decreased appetite—Irinotecan—lung cancer	0.000417	0.00129	CcSEcCtD
Fosamprenavir—Nausea—Vinblastine—lung cancer	0.000416	0.00129	CcSEcCtD
Fosamprenavir—Anorexia—Cisplatin—lung cancer	0.000416	0.00129	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Irinotecan—lung cancer	0.000414	0.00128	CcSEcCtD
Fosamprenavir—Fatigue—Irinotecan—lung cancer	0.000414	0.00128	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000414	0.00128	CcSEcCtD
Fosamprenavir—Pruritus—Vinorelbine—lung cancer	0.000412	0.00128	CcSEcCtD
Fosamprenavir—Myalgia—Paclitaxel—lung cancer	0.000408	0.00127	CcSEcCtD
Fosamprenavir—Malnutrition—Docetaxel—lung cancer	0.000407	0.00126	CcSEcCtD
Fosamprenavir—Decreased appetite—Gemcitabine—lung cancer	0.000407	0.00126	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000406	0.00126	CcSEcCtD
Fosamprenavir—Nausea—Topotecan—lung cancer	0.000404	0.00125	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000404	0.00125	CcSEcCtD
Fosamprenavir—Fatigue—Gemcitabine—lung cancer	0.000403	0.00125	CcSEcCtD
Fosamprenavir—Nausea—Erlotinib—lung cancer	0.0004	0.00124	CcSEcCtD
Fosamprenavir—Diarrhoea—Vinorelbine—lung cancer	0.000398	0.00123	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000397	0.00123	CcSEcCtD
Fosamprenavir—Neutropenia—Methotrexate—lung cancer	0.000393	0.00122	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Irinotecan—lung cancer	0.000393	0.00122	CcSEcCtD
Fosamprenavir—Skin disorder—Etoposide—lung cancer	0.000388	0.0012	CcSEcCtD
Fosamprenavir—Dizziness—Vinorelbine—lung cancer	0.000385	0.00119	CcSEcCtD
Fosamprenavir—Nervous system disorder—Paclitaxel—lung cancer	0.000384	0.00119	CcSEcCtD
Fosamprenavir—Anorexia—Etoposide—lung cancer	0.000381	0.00118	CcSEcCtD
Fosamprenavir—Skin disorder—Paclitaxel—lung cancer	0.00038	0.00118	CcSEcCtD
Fosamprenavir—Abdominal pain—Irinotecan—lung cancer	0.00038	0.00118	CcSEcCtD
Fosamprenavir—Body temperature increased—Irinotecan—lung cancer	0.00038	0.00118	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000379	0.00118	CcSEcCtD
Fosamprenavir—Decreased appetite—Cisplatin—lung cancer	0.000379	0.00117	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Cisplatin—lung cancer	0.000376	0.00117	CcSEcCtD
Fosamprenavir—Anorexia—Paclitaxel—lung cancer	0.000373	0.00116	CcSEcCtD
Fosamprenavir—Gastritis—Doxorubicin—lung cancer	0.000373	0.00116	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000372	0.00115	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000372	0.00115	CcSEcCtD
Fosamprenavir—Vomiting—Vinorelbine—lung cancer	0.00037	0.00115	CcSEcCtD
Fosamprenavir—Body temperature increased—Gemcitabine—lung cancer	0.00037	0.00115	CcSEcCtD
Fosamprenavir—Rash—Vinorelbine—lung cancer	0.000367	0.00114	CcSEcCtD
Fosamprenavir—Dermatitis—Vinorelbine—lung cancer	0.000367	0.00114	CcSEcCtD
Fosamprenavir—Headache—Vinorelbine—lung cancer	0.000365	0.00113	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000357	0.00111	CcSEcCtD
Fosamprenavir—Hypersensitivity—Irinotecan—lung cancer	0.000354	0.0011	CcSEcCtD
Fosamprenavir—Decreased appetite—Etoposide—lung cancer	0.000347	0.00108	CcSEcCtD
Fosamprenavir—Myalgia—Docetaxel—lung cancer	0.000346	0.00107	CcSEcCtD
Fosamprenavir—Nausea—Vinorelbine—lung cancer	0.000346	0.00107	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Etoposide—lung cancer	0.000345	0.00107	CcSEcCtD
Fosamprenavir—Body temperature increased—Cisplatin—lung cancer	0.000345	0.00107	CcSEcCtD
Fosamprenavir—Asthenia—Irinotecan—lung cancer	0.000344	0.00107	CcSEcCtD
Fosamprenavir—Fatigue—Etoposide—lung cancer	0.000344	0.00107	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000344	0.00107	CcSEcCtD
Fosamprenavir—Neutropenia—Doxorubicin—lung cancer	0.000341	0.00106	CcSEcCtD
Fosamprenavir—Decreased appetite—Paclitaxel—lung cancer	0.00034	0.00105	CcSEcCtD
Fosamprenavir—Haemoglobin—Methotrexate—lung cancer	0.000338	0.00105	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000338	0.00105	CcSEcCtD
Fosamprenavir—Fatigue—Paclitaxel—lung cancer	0.000338	0.00105	CcSEcCtD
Fosamprenavir—Haemorrhage—Methotrexate—lung cancer	0.000337	0.00104	CcSEcCtD
Fosamprenavir—Asthenia—Gemcitabine—lung cancer	0.000336	0.00104	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Methotrexate—lung cancer	0.000333	0.00103	CcSEcCtD
Fosamprenavir—Pruritus—Gemcitabine—lung cancer	0.000331	0.00103	CcSEcCtD
Fosamprenavir—Urethral disorder—Methotrexate—lung cancer	0.00033	0.00102	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Doxorubicin—lung cancer	0.000329	0.00102	CcSEcCtD
Fosamprenavir—Diarrhoea—Irinotecan—lung cancer	0.000328	0.00102	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Etoposide—lung cancer	0.000327	0.00101	CcSEcCtD
Fosamprenavir—Nervous system disorder—Docetaxel—lung cancer	0.000325	0.00101	CcSEcCtD
Fosamprenavir—Skin disorder—Docetaxel—lung cancer	0.000322	0.000999	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000322	0.000998	CcSEcCtD
Fosamprenavir—Hypersensitivity—Cisplatin—lung cancer	0.000321	0.000995	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Paclitaxel—lung cancer	0.00032	0.000992	CcSEcCtD
Fosamprenavir—Diarrhoea—Gemcitabine—lung cancer	0.00032	0.000992	CcSEcCtD
Fosamprenavir—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.000319	0.0291	CbGpPWpGaD
Fosamprenavir—Erythema multiforme—Methotrexate—lung cancer	0.000318	0.000987	CcSEcCtD
Fosamprenavir—Dizziness—Irinotecan—lung cancer	0.000317	0.000984	CcSEcCtD
Fosamprenavir—Anorexia—Docetaxel—lung cancer	0.000316	0.00098	CcSEcCtD
Fosamprenavir—Body temperature increased—Etoposide—lung cancer	0.000316	0.000978	CcSEcCtD
Fosamprenavir—Abdominal pain—Etoposide—lung cancer	0.000316	0.000978	CcSEcCtD
Fosamprenavir—Asthenia—Cisplatin—lung cancer	0.000313	0.000969	CcSEcCtD
Fosamprenavir—Cardiac disorder—Methotrexate—lung cancer	0.000312	0.000968	CcSEcCtD
Fosamprenavir—Body temperature increased—Paclitaxel—lung cancer	0.00031	0.000959	CcSEcCtD
Fosamprenavir—Abdominal pain—Paclitaxel—lung cancer	0.00031	0.000959	CcSEcCtD
Fosamprenavir—Vomiting—Irinotecan—lung cancer	0.000305	0.000946	CcSEcCtD
Fosamprenavir—Immune system disorder—Methotrexate—lung cancer	0.000304	0.000942	CcSEcCtD
Fosamprenavir—Rash—Irinotecan—lung cancer	0.000303	0.000938	CcSEcCtD
Fosamprenavir—Dermatitis—Irinotecan—lung cancer	0.000302	0.000937	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000302	0.000937	CcSEcCtD
Fosamprenavir—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.000302	0.0276	CbGpPWpGaD
Fosamprenavir—Headache—Irinotecan—lung cancer	0.000301	0.000932	CcSEcCtD
Fosamprenavir—Diarrhoea—Cisplatin—lung cancer	0.000298	0.000924	CcSEcCtD
Fosamprenavir—Vomiting—Gemcitabine—lung cancer	0.000297	0.000922	CcSEcCtD
Fosamprenavir—Rash—Gemcitabine—lung cancer	0.000295	0.000914	CcSEcCtD
Fosamprenavir—Dermatitis—Gemcitabine—lung cancer	0.000295	0.000913	CcSEcCtD
Fosamprenavir—Hypersensitivity—Etoposide—lung cancer	0.000294	0.000912	CcSEcCtD
Fosamprenavir—Malnutrition—Methotrexate—lung cancer	0.000293	0.000908	CcSEcCtD
Fosamprenavir—Haemoglobin—Doxorubicin—lung cancer	0.000293	0.000908	CcSEcCtD
Fosamprenavir—Headache—Gemcitabine—lung cancer	0.000293	0.000908	CcSEcCtD
Fosamprenavir—Haemorrhage—Doxorubicin—lung cancer	0.000292	0.000904	CcSEcCtD
Fosamprenavir—Decreased appetite—Docetaxel—lung cancer	0.000289	0.000894	CcSEcCtD
Fosamprenavir—Hypersensitivity—Paclitaxel—lung cancer	0.000288	0.000894	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Doxorubicin—lung cancer	0.000288	0.000892	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Docetaxel—lung cancer	0.000287	0.000888	CcSEcCtD
Fosamprenavir—Asthenia—Etoposide—lung cancer	0.000287	0.000888	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Doxorubicin—lung cancer	0.000286	0.000888	CcSEcCtD
Fosamprenavir—Fatigue—Docetaxel—lung cancer	0.000286	0.000887	CcSEcCtD
Fosamprenavir—Urethral disorder—Doxorubicin—lung cancer	0.000286	0.000886	CcSEcCtD
Fosamprenavir—Nausea—Irinotecan—lung cancer	0.000285	0.000884	CcSEcCtD
Fosamprenavir—Pruritus—Etoposide—lung cancer	0.000283	0.000876	CcSEcCtD
Fosamprenavir—Asthenia—Paclitaxel—lung cancer	0.000281	0.000871	CcSEcCtD
Fosamprenavir—Nausea—Gemcitabine—lung cancer	0.000278	0.000861	CcSEcCtD
Fosamprenavir—Vomiting—Cisplatin—lung cancer	0.000277	0.000859	CcSEcCtD
Fosamprenavir—Pruritus—Paclitaxel—lung cancer	0.000277	0.000859	CcSEcCtD
Fosamprenavir—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.000276	0.0252	CbGpPWpGaD
Fosamprenavir—Erythema multiforme—Doxorubicin—lung cancer	0.000276	0.000854	CcSEcCtD
Fosamprenavir—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000275	0.0251	CbGpPWpGaD
Fosamprenavir—Rash—Cisplatin—lung cancer	0.000275	0.000852	CcSEcCtD
Fosamprenavir—Dermatitis—Cisplatin—lung cancer	0.000275	0.000851	CcSEcCtD
Fosamprenavir—Diarrhoea—Etoposide—lung cancer	0.000273	0.000847	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Docetaxel—lung cancer	0.000271	0.000841	CcSEcCtD
Fosamprenavir—Cardiac disorder—Doxorubicin—lung cancer	0.000271	0.000839	CcSEcCtD
Fosamprenavir—Diarrhoea—Paclitaxel—lung cancer	0.000268	0.00083	CcSEcCtD
Fosamprenavir—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.000266	0.0243	CbGpPWpGaD
Fosamprenavir—Dizziness—Etoposide—lung cancer	0.000264	0.000818	CcSEcCtD
Fosamprenavir—Immune system disorder—Doxorubicin—lung cancer	0.000263	0.000816	CcSEcCtD
Fosamprenavir—Body temperature increased—Docetaxel—lung cancer	0.000262	0.000813	CcSEcCtD
Fosamprenavir—Abdominal pain—Docetaxel—lung cancer	0.000262	0.000813	CcSEcCtD
Fosamprenavir—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.000262	0.0239	CbGpPWpGaD
Fosamprenavir—Dizziness—Paclitaxel—lung cancer	0.000259	0.000802	CcSEcCtD
Fosamprenavir—Nausea—Cisplatin—lung cancer	0.000259	0.000802	CcSEcCtD
Fosamprenavir—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.000256	0.0234	CbGpPWpGaD
Fosamprenavir—Vomiting—Etoposide—lung cancer	0.000254	0.000787	CcSEcCtD
Fosamprenavir—Malnutrition—Doxorubicin—lung cancer	0.000254	0.000787	CcSEcCtD
Fosamprenavir—Rash—Etoposide—lung cancer	0.000252	0.00078	CcSEcCtD
Fosamprenavir—Dermatitis—Etoposide—lung cancer	0.000252	0.00078	CcSEcCtD
Fosamprenavir—Headache—Etoposide—lung cancer	0.00025	0.000775	CcSEcCtD
Fosamprenavir—Flatulence—Doxorubicin—lung cancer	0.00025	0.000775	CcSEcCtD
Fosamprenavir—Myalgia—Methotrexate—lung cancer	0.00025	0.000773	CcSEcCtD
Fosamprenavir—Vomiting—Paclitaxel—lung cancer	0.000249	0.000772	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000248	0.000768	CcSEcCtD
Fosamprenavir—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.000247	0.0226	CbGpPWpGaD
Fosamprenavir—Rash—Paclitaxel—lung cancer	0.000247	0.000765	CcSEcCtD
Fosamprenavir—Dermatitis—Paclitaxel—lung cancer	0.000247	0.000764	CcSEcCtD
Fosamprenavir—Headache—Paclitaxel—lung cancer	0.000245	0.00076	CcSEcCtD
Fosamprenavir—Hypersensitivity—Docetaxel—lung cancer	0.000245	0.000758	CcSEcCtD
Fosamprenavir—Asthenia—Docetaxel—lung cancer	0.000238	0.000738	CcSEcCtD
Fosamprenavir—Nausea—Etoposide—lung cancer	0.000237	0.000735	CcSEcCtD
Fosamprenavir—Pruritus—Docetaxel—lung cancer	0.000235	0.000728	CcSEcCtD
Fosamprenavir—Nervous system disorder—Methotrexate—lung cancer	0.000235	0.000727	CcSEcCtD
Fosamprenavir—Nausea—Paclitaxel—lung cancer	0.000233	0.000721	CcSEcCtD
Fosamprenavir—Skin disorder—Methotrexate—lung cancer	0.000232	0.00072	CcSEcCtD
Fosamprenavir—Anorexia—Methotrexate—lung cancer	0.000228	0.000707	CcSEcCtD
Fosamprenavir—Diarrhoea—Docetaxel—lung cancer	0.000227	0.000704	CcSEcCtD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000221	0.0202	CbGpPWpGaD
Fosamprenavir—Dizziness—Docetaxel—lung cancer	0.000219	0.00068	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000218	0.000675	CcSEcCtD
Fosamprenavir—Myalgia—Doxorubicin—lung cancer	0.000216	0.00067	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000215	0.000665	CcSEcCtD
Fosamprenavir—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000214	0.0196	CbGpPWpGaD
Fosamprenavir—Vomiting—Docetaxel—lung cancer	0.000211	0.000654	CcSEcCtD
Fosamprenavir—Rash—Docetaxel—lung cancer	0.000209	0.000649	CcSEcCtD
Fosamprenavir—Dermatitis—Docetaxel—lung cancer	0.000209	0.000648	CcSEcCtD
Fosamprenavir—Decreased appetite—Methotrexate—lung cancer	0.000208	0.000644	CcSEcCtD
Fosamprenavir—Headache—Docetaxel—lung cancer	0.000208	0.000644	CcSEcCtD
Fosamprenavir—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.000207	0.0189	CbGpPWpGaD
Fosamprenavir—Gastrointestinal disorder—Methotrexate—lung cancer	0.000207	0.00064	CcSEcCtD
Fosamprenavir—Fatigue—Methotrexate—lung cancer	0.000206	0.000639	CcSEcCtD
Fosamprenavir—Nervous system disorder—Doxorubicin—lung cancer	0.000203	0.00063	CcSEcCtD
Fosamprenavir—Skin disorder—Doxorubicin—lung cancer	0.000201	0.000624	CcSEcCtD
Fosamprenavir—Anorexia—Doxorubicin—lung cancer	0.000197	0.000612	CcSEcCtD
Fosamprenavir—Nausea—Docetaxel—lung cancer	0.000197	0.000611	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Methotrexate—lung cancer	0.000196	0.000606	CcSEcCtD
Fosamprenavir—Body temperature increased—Methotrexate—lung cancer	0.000189	0.000586	CcSEcCtD
Fosamprenavir—Abdominal pain—Methotrexate—lung cancer	0.000189	0.000586	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000189	0.000585	CcSEcCtD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000188	0.0172	CbGpPWpGaD
Fosamprenavir—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000185	0.0169	CbGpPWpGaD
Fosamprenavir—Decreased appetite—Doxorubicin—lung cancer	0.00018	0.000558	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000179	0.000554	CcSEcCtD
Fosamprenavir—Fatigue—Doxorubicin—lung cancer	0.000179	0.000553	CcSEcCtD
Fosamprenavir—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000178	0.0163	CbGpPWpGaD
Fosamprenavir—Hypersensitivity—Methotrexate—lung cancer	0.000176	0.000546	CcSEcCtD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000174	0.0159	CbGpPWpGaD
Fosamprenavir—Asthenia—Methotrexate—lung cancer	0.000172	0.000532	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Doxorubicin—lung cancer	0.000169	0.000525	CcSEcCtD
Fosamprenavir—Pruritus—Methotrexate—lung cancer	0.000169	0.000524	CcSEcCtD
Fosamprenavir—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000169	0.0155	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000166	0.0152	CbGpPWpGaD
Fosamprenavir—Abdominal pain—Doxorubicin—lung cancer	0.000164	0.000507	CcSEcCtD
Fosamprenavir—Body temperature increased—Doxorubicin—lung cancer	0.000164	0.000507	CcSEcCtD
Fosamprenavir—Diarrhoea—Methotrexate—lung cancer	0.000164	0.000507	CcSEcCtD
Fosamprenavir—Dizziness—Methotrexate—lung cancer	0.000158	0.00049	CcSEcCtD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000158	0.0144	CbGpPWpGaD
Fosamprenavir—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000157	0.0144	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000156	0.0142	CbGpPWpGaD
Fosamprenavir—Hypersensitivity—Doxorubicin—lung cancer	0.000153	0.000473	CcSEcCtD
Fosamprenavir—Vomiting—Methotrexate—lung cancer	0.000152	0.000471	CcSEcCtD
Fosamprenavir—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000151	0.0138	CbGpPWpGaD
Fosamprenavir—Rash—Methotrexate—lung cancer	0.000151	0.000467	CcSEcCtD
Fosamprenavir—Dermatitis—Methotrexate—lung cancer	0.000151	0.000467	CcSEcCtD
Fosamprenavir—Headache—Methotrexate—lung cancer	0.00015	0.000464	CcSEcCtD
Fosamprenavir—Asthenia—Doxorubicin—lung cancer	0.000149	0.000461	CcSEcCtD
Fosamprenavir—Pruritus—Doxorubicin—lung cancer	0.000147	0.000454	CcSEcCtD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000144	0.0132	CbGpPWpGaD
Fosamprenavir—Nausea—Methotrexate—lung cancer	0.000142	0.00044	CcSEcCtD
Fosamprenavir—Diarrhoea—Doxorubicin—lung cancer	0.000142	0.000439	CcSEcCtD
Fosamprenavir—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.00014	0.0128	CbGpPWpGaD
Fosamprenavir—Dizziness—Doxorubicin—lung cancer	0.000137	0.000424	CcSEcCtD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000135	0.0124	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000132	0.0121	CbGpPWpGaD
Fosamprenavir—Vomiting—Doxorubicin—lung cancer	0.000132	0.000408	CcSEcCtD
Fosamprenavir—Rash—Doxorubicin—lung cancer	0.000131	0.000405	CcSEcCtD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000131	0.0119	CbGpPWpGaD
Fosamprenavir—Dermatitis—Doxorubicin—lung cancer	0.00013	0.000404	CcSEcCtD
Fosamprenavir—Headache—Doxorubicin—lung cancer	0.00013	0.000402	CcSEcCtD
Fosamprenavir—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.00013	0.0119	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000127	0.0116	CbGpPWpGaD
Fosamprenavir—Nausea—Doxorubicin—lung cancer	0.000123	0.000381	CcSEcCtD
Fosamprenavir—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000123	0.0112	CbGpPWpGaD
Fosamprenavir—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000118	0.0108	CbGpPWpGaD
Fosamprenavir—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000113	0.0103	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000109	0.00994	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000107	0.0098	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000103	0.00941	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	8.43e-05	0.00771	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	8.08e-05	0.00739	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	8.03e-05	0.00734	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	7.68e-05	0.00702	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	7.58e-05	0.00693	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	6.53e-05	0.00597	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CAT—lung cancer	6.48e-05	0.00593	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	6.45e-05	0.00589	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTM2—lung cancer	6.3e-05	0.00576	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CNDP2—lung cancer	6.3e-05	0.00576	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	6.23e-05	0.00569	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	6.21e-05	0.00568	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	5.8e-05	0.00531	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP2A7—lung cancer	5.7e-05	0.00521	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	5.62e-05	0.00514	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	5.3e-05	0.00484	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTA3—lung cancer	5.08e-05	0.00464	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	5.01e-05	0.00458	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	4.69e-05	0.00429	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTA4—lung cancer	4.64e-05	0.00424	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	4.63e-05	0.00423	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	4.58e-05	0.00419	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTA2—lung cancer	4.52e-05	0.00414	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTA1—lung cancer	4.37e-05	0.00399	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	4.12e-05	0.00377	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—UGT1A1—lung cancer	4.06e-05	0.00371	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	4e-05	0.00366	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	3.8e-05	0.00348	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	3.58e-05	0.00327	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	3.5e-05	0.0032	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—HPGDS—lung cancer	3.45e-05	0.00315	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTT1—lung cancer	3.35e-05	0.00306	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GCLC—lung cancer	3.31e-05	0.00302	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP2A6—lung cancer	3.31e-05	0.00302	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	2.84e-05	0.00259	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP2E1—lung cancer	2.81e-05	0.00257	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	2.77e-05	0.00254	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTP1—lung cancer	2.32e-05	0.00212	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.29e-05	0.00209	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.13e-05	0.00195	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.1e-05	0.00192	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.02e-05	0.00185	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.99e-05	0.00182	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.78e-05	0.00163	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—AZIN2—lung cancer	1.78e-05	0.00163	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ATP5H—lung cancer	1.51e-05	0.00138	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—POMC—lung cancer	1.51e-05	0.00138	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PLBD1—lung cancer	1.35e-05	0.00123	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HSD17B10—lung cancer	1.23e-05	0.00113	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CKB—lung cancer	1.15e-05	0.00105	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTM2—lung cancer	1.08e-05	0.000985	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CNDP2—lung cancer	1.08e-05	0.000985	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—MTMR3—lung cancer	1.05e-05	0.000958	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PGAM1—lung cancer	1.02e-05	0.000933	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP2A7—lung cancer	9.74e-06	0.00089	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SDC4—lung cancer	9.53e-06	0.000871	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTA3—lung cancer	8.68e-06	0.000794	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—RRM1—lung cancer	8.68e-06	0.000794	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—B4GALT5—lung cancer	8.16e-06	0.000746	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTA4—lung cancer	7.94e-06	0.000726	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTA2—lung cancer	7.74e-06	0.000707	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTA1—lung cancer	7.47e-06	0.000682	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ABCC3—lung cancer	7.38e-06	0.000675	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—AKR1C1—lung cancer	7.15e-06	0.000654	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—UGT1A1—lung cancer	6.94e-06	0.000634	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GNG11—lung cancer	6.69e-06	0.000612	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALDOA—lung cancer	6.37e-06	0.000582	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—NCOA3—lung cancer	6.19e-06	0.000565	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ADCY1—lung cancer	6.02e-06	0.00055	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ABCG2—lung cancer	6.02e-06	0.00055	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ENO2—lung cancer	5.9e-06	0.000539	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HPGDS—lung cancer	5.9e-06	0.000539	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.86e-06	0.000536	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTT1—lung cancer	5.72e-06	0.000523	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP2A6—lung cancer	5.66e-06	0.000517	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GCLC—lung cancer	5.66e-06	0.000517	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ENO1—lung cancer	5.36e-06	0.00049	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP2E1—lung cancer	4.81e-06	0.00044	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—NQO1—lung cancer	4.76e-06	0.000435	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—STK11—lung cancer	4.29e-06	0.000392	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTP1—lung cancer	3.97e-06	0.000363	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CAT—lung cancer	3.86e-06	0.000353	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ABCB1—lung cancer	3.76e-06	0.000343	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—TYMS—lung cancer	3.69e-06	0.000337	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTM1—lung cancer	3.65e-06	0.000333	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP1A1—lung cancer	3.46e-06	0.000316	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ERCC2—lung cancer	3.43e-06	0.000313	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—APOA1—lung cancer	2.97e-06	0.000271	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PIK3CG—lung cancer	2.71e-06	0.000247	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—POMC—lung cancer	2.58e-06	0.000236	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CREBBP—lung cancer	2.51e-06	0.000229	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PIK3CD—lung cancer	2.38e-06	0.000218	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALB—lung cancer	2.35e-06	0.000215	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PIK3CB—lung cancer	2.07e-06	0.00019	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PTGS2—lung cancer	2.06e-06	0.000188	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PTEN—lung cancer	1.79e-06	0.000164	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—EP300—lung cancer	1.71e-06	0.000156	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PIK3CA—lung cancer	1.26e-06	0.000116	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—AKT1—lung cancer	1.03e-06	9.44e-05	CbGpPWpGaD
